To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Summary

A multicenter, open phase I clinical study to evaluate the safety, tolerance and pharmacokinetics of BAT8007 for injection in patients with advanced solid tumors.

Timeline

Start

2023-01-17

Primary completion

2025-08-18

Completion

2026-03-31

Outcome

Outcome not reported

Stopped (Business): “Due to the adjustment of our company's research and development strategy, we are now prematurely terminating this project.”

Drugs

Indications